BC
BIIB icon

Brookfield Corp’s Biogen BIIB Stock Holding History

Brookfield Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-26,305
Closed -$7.49M – 164
2023
Q2 		$7.49M Sell
26,305
-7,022
-21% -$2.09M 0.03% 197
2023
Q1 		$9.27M Buy
33,327
+11,947
+56% +$3.31M 0.04% 184
2022
Q4 		$5.92M Sell
21,380
-5,066
-19% -$1.43M 0.02% 231
2022
Q3 		$7.06M Buy
+26,446
New +$5.62M 0.03% 223
2022
Q2 		– Sell
-14,763
Closed -$3.11M – 606
2022
Q1 		$3.11M Buy
14,763
+10,763
+269% +$2.34M 0.01% 334
2021
Q4 		$960K Buy
4,000
+1,290
+48% +$332K ﹤0.01% 458
2021
Q3 		$767K Buy
2,710
+825
+44% +$270K ﹤0.01% 450
2021
Q2 		$653K Buy
+1,885
New +$571K ﹤0.01% 495

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brookfield Corp's BIIB Position: Q3 2023 in Review

Brookfield Corp sold out of Biogen (BIIB) in Q3 2023, closing a stake of 26,305 shares — an estimated $7.49M sold.

Brookfield Corp first reported a position in BIIB in Q2 2021 and held it in 8 quarters. The position peaked at $9.27M in Q1 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Brookfield Corp reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 26,305 Biogen shares in Q3 2023, an estimated $7.49M.
  • Brookfield Corp first reported a position in Biogen in Q2 2021 and held it in 8 quarters.
  • Brookfield Corp's Biogen position peaked at $9.27M in Q1 2023.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.